FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 18 THROUGH 64 YEARS OF AGE THAT PUTS THEM AT HIGH RISK
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.62 USD | -0.09% | +0.71% | -0.52% |
04:40pm | Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft... | |
01:25pm | DA Davidson Raises Price Target on Pfizer to $35 From $30, Maintains Buy/Add Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.52% | 162B | |
+33.48% | 693B | |
+29.39% | 584B | |
-2.65% | 372B | |
+20.64% | 332B | |
+6.99% | 294B | |
+14.02% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.13% | 168B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Fda Says Authorizes Booster Dose Of Pfizer-Biontech Covid-19 Vaccine For Individuals 18 Through 64 Years Of Age That Puts Them At High Risk